San Francisco-based healthcare AI startup ClarityCare has raised $16.5 million in an oversubscribed Series A round to expand its AI-powered healthcare administration platform, bringing its total funding to nearly $20 million. The round was led by Headline, with participation from new investors Arthur Ventures and FJ Labs, alongside existing backers Maverick Ventures, firstminute capital, Top Harvest Capital and Transpose Platform.
Founded by Hermine Tranie (CEO) and Alex Andrei (CTO), ClarityCare develops AI agents that automate administrative and clinical workflows for health insurers, health plans and third-party administrators. Its platform, Electra, is designed to reduce manual processing in utilization management, helping healthcare organisations review treatment requests, assess clinical information and communicate decisions more efficiently.
Automating Healthcare Administration With AI Agents
Healthcare payers manage large volumes of prior authorization requests, which require them to review medical documentation, check insurance benefits and assess whether proposed treatments meet clinical guidelines. These processes often involve fragmented systems, manual data entry and fax-based communications, creating administrative work for clinical teams and potentially delaying patient access to care.
ClarityCare’s Electra platform uses AI agents to handle these workflows within existing healthcare systems. The technology reviews incoming requests against clinical guidelines and member benefits, prepares recommendations and maintains an audit trail documenting how each recommendation was reached. It can approve or escalate cases for further review but does not issue denials, leaving decisions that require additional clinical judgment to healthcare professionals.
The company has expanded Electra’s capabilities to manage more of the authorization process from beginning to end. The platform can now process requests from additional fax inboxes, create cases within utilization management systems, generate letters and send outbound faxes to complete authorization workflows. New agentic capabilities also allow Electra to adapt to different client configurations and accommodate changes in operational requirements.
ClarityCare develops its technology through collaboration between engineers and clinical professionals, including nurses who help design and evaluate the system’s workflows. The company positions Electra as an AI services platform rather than a standalone software tool, with the aim of automating routine administrative tasks while allowing clinical teams to concentrate on more complex cases.
Funding to Support Product Development and Government Expansion
The $16.5 million Series A follows ClarityCare’s earlier funding rounds and brings its total capital raised to nearly $20 million. The investment was led by Headline, whose co-founder and managing partner Mathias Schilling highlighted the founders’ combination of technical expertise and understanding of healthcare administration.
The company plans to use the new capital to expand its team, develop additional products and increase its presence in the government healthcare sector. ClarityCare is currently recruiting across engineering, clinical and sales functions, while also looking for a new office in the San Francisco Bay Area.
Its expansion comes as healthcare organisations face growing pressure to process authorization requests efficiently while maintaining compliance with clinical and regulatory requirements. By integrating AI agents into existing payer systems, ClarityCare aims to reduce the administrative work involved in managing requests without removing clinical oversight from the process.
With the new funding, ClarityCare will continue developing Electra’s automation capabilities and extending its platform into additional healthcare operations, focusing on workflows that connect clinical review, case management and communication with providers.
